BIOSYNTH GROUP LIMITED

13690981
Active Newbury

Activities of other holding companies n.e.c.

602 employees website.com
Life sciences and medical technology Activities of other holding companies n.e.c.
B

BIOSYNTH GROUP LIMITED

13690981

Activities of other holding companies n.e.c.

Founded 20 Oct 2021 Active Newbury, England 602 employees website.com
Life sciences and medical technology Activities of other holding companies n.e.c.

Previous Company Names

GALLUS BIDCO LIMITED 20 Oct 2021 — 21 Jun 2023
Accounts Submitted 11 Jul 2025 Next due 30 Sept 2026 2 months remaining
Confirmation Submitted 21 Oct 2025 Next due 2 Nov 2026 4 months remaining
Net assets £183M £33M 2024 year on year
Total assets £327M £51M 2024 year on year
Total Liabilities £144M £18M 2024 year on year
Charges 2
2 outstanding

Contact & Details

Contact

Registered Address

8&9 Old Station Business Park Compton Newbury RG20 6NE England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for BIOSYNTH GROUP LIMITED (13690981), an active life sciences and medical technology company based in Newbury, England. Incorporated 20 Oct 2021. Activities of other holding companies n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type group
Next accounts 31 Dec 2025
Due by 30 Sept 2026 2 months remaining

Balance Sheet & P&L (2022–2024)

Cash in Bank

£11.66M

Decreased by £4.76M (-29%)

Net Assets

£182.85M

Decreased by £33.06M (-15%)

Total Liabilities

£144.02M

Decreased by £17.60M (-11%)

Turnover

£86.59M

Increased by £5.55M (+7%)

Employees

602

Increased by 48 (+9%)

Debt Ratio

44%

Increased by 1 (+2%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

16 Allotments 320,499,779 Shares £244.75m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
7 May 2026200$210k$1k
27 Jun 20259,000$9.00m$1k
18 Jun 20251,000$1k$1k
28 May 20255,000$5.00m$1k
25 Nov 2024750$14.99m$20k

Officers

Officers

1 active 2 resigned
Status
Eric Brian LevDirectorAmericanUnited States5016 Mar 2022Active

Shareholders

Shareholders (1)

Biosynth Group Holdings Limited
100.0%
334,374,612

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

BIOSYNTH GROUP LIMITED Current Company
PEPCEUTICALS LTD united kingdom

Charges

Charges

2 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
20 Jun 2026IncorporationMemorandum Articles
20 Jun 2026ResolutionResolutions
28 May 2026OfficersTermination of Urs Philipp Spitz as director on 28 May 2026
18 May 2026CapitalAllotment of shares (USD 3,343,748.12) on 7 May 2026
21 Oct 2025CapitalAllotment of shares (USD 3,343,656.12) on 18 Jun 2025
20 Jun 2026 Incorporation

Memorandum Articles

20 Jun 2026 Resolution

Resolutions

28 May 2026 Officers

Termination of Urs Philipp Spitz as director on 28 May 2026

18 May 2026 Capital

Allotment of shares (USD 3,343,748.12) on 7 May 2026

21 Oct 2025 Capital

Allotment of shares (USD 3,343,656.12) on 18 Jun 2025

Recent Activity

Latest Activity

Memorandum Articles

2 weeks ago on 20 Jun 2026

Resolutions

2 weeks ago on 20 Jun 2026

Termination of Urs Philipp Spitz as director on 28 May 2026

1 months ago on 28 May 2026

Allotment of shares (USD 3,343,748.12) on 7 May 2026

1 months ago on 18 May 2026

Allotment of shares (USD 3,343,656.12) on 18 Jun 2025

8 months ago on 21 Oct 2025